Tenderwize
Back to tender search

Open House Discount Agreement for Urapidil

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 195 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Urapidil, ATC C02CA06

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

EU funding flag inconsistency: structured data says EU funded, XML notice says no EU funds. May affect eligibility or r...

Possibility that open house contracts are replaced by exclusive contracts during term, terminating open house agreement...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Pharmaceutical products with active ingredient Urapidil (ATC C02CA06)
  • Non-exclusive discount agreements under §130a Abs. 8/130c Abs. 1 SGB V
Show full summary

Open house non-exclusive discount agreement for the active ingredient Urapidil (ATC C02CA06) under German social code SGB V. Contract period 01.05.2025–30.04.2027 with rolling enrollment. No competitive selection; all eligible pharmaceutical companies can join. No estimated value provided. EU funding flag inconsistent (structured data: true, XML notice: false). Electronic submission not allowed.

Risks

EU funding flag inconsistency: structured data says EU funded, XML notice says no EU funds. May affect eligibility or r...

Possibility that open house contracts are replaced by exclusive contracts during term, terminating open house agreement...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Pharmaceutical company must be a 'pharmazeutischer Unternehmer' authorized to market Urapidil products in Germany
  • Drugs must be authorized and marketable in Germany (listed in Lauer-Taxe or verified via AMIce database)

Administrative

  • Submission of signed contract documents, proof of marketability, and authorization evidence

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open House Discount Agreement for Urapidil

Non-exclusive discount contract for Urapidil pharmaceuticals. Uniform terms, no negotiations. Contracts run up to 24 months, ending no later than 30.04.2027. First enrollment deadline 31.03.2025 for start 01.05.2025. Subsequent enrollments possible each month.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Feb 28, 2027

Procurement Details

Publication date
12 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
162677-2025

Documents (1)

Similar tenders